FindTrial
Sign In

The evaluation of Xiaohan Liqi Decoction‘s clinical efficacy and safety in the treatment of OSAHS patients with phlegm-dampness constitution

Correlation between obstructive sleep apnea hypopnea syndrome and TCM constitution and evaluation of clinical efficacy of Xiaohan Liqi Decoction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022617
Enrollment
Unknown
Registered
2019-04-19
Start date
2019-04-22
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obstructive sleep apnea hypopnea syndrome

Interventions

therapy group:Xiaohan Liqi Decoction+basic treatment
control group:basic treatment

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20 to 75 years, male and female; 2. Conform to the diagnostic criteria of OSAHS and phlegm-dampness constitution; 3. Subjects are informed, voluntary signing informed consent; 4. Agreed to accept Chinese medicine treatment; 5. Agreed to follow-up.

Exclusion criteria

Exclusion criteria: 1. Combined with severe primary diseases such as heart failure, cerebrovascular disease, and renal insufficiency; 2. With mental diseases; 3. Pregnancy, planning to become pregnant, lactation women; 4. Subjects who are taking part in other drugs clinical trials in recent four weeks; 5. People who are allergic to the test drugs.

Design outcomes

Primary

MeasureTime frame
AHI;—

Secondary

MeasureTime frame
SpO2;PSG;TCM symptom scores;Epworth sleepiness scale;SAQLI;—

Countries

China

Contacts

Public ContactCuiling Feng
fengcuiling@sina.com+86 010-88325885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026